Demystifying the Role of Histone Demethylases in Colorectal Cancer: Mechanisms and Therapeutic Opportunities
Open Access
- 9 April 2025
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (4) , 267
Abstract
Histone demethylases (HDMs) play a pivotal role in colorectal cancer (CRC) progression through dynamic epigenetic regulation. This review summarizes the role and therapeutic potential of HDM in CRC. HDMs primarily target lysine (K) for demethylation (lysine demethylase, KDM). The KDM family is divided into the lysine-specific demethylase family and the Jumonji C domain-containing family. HDMs play complex roles in CRC cell proliferation, invasion, migration, stemness, epithelial–mesenchymal transition, immune response, and chemoresistance through epigenetic regulation of different histone demethylation sites. Increasing evidence suggests that KDM may interact with certain factors and regulate CRC tumorigenesis by modulating multiple signaling pathways and affecting the transcription of target genes. These processes may be regulated by upstream genes and thus form a complex epigenetic regulatory network. However, the potential roles and regulatory mechanisms of some HDMs in CRC remain understudied. Preclinical studies have revealed that small-molecule inhibitors targeting HDM impact the activity of specific genes and pathways by inhibiting specific HDM expression, thereby reshaping the tumorigenic landscape of CRC. However, the clinical translational potential of these inhibitors remains unexplored. In conclusion, HDMs play a complex and critical role in CRC progression by dynamically regulating histone methylation patterns. These HDMs shape the malignant behavior of CRC by influencing the activity of key pathways and target genes through epigenetic reprogramming. Targeting HDM may be a promising direction for CRC treatment. Further exploration of the role of specific HDMs in CRC and the therapeutic potential of HDM-specific inhibitors is needed in the future.Keywords
Funding Information
- Wuhan Health and Family Planning Commission Medical Research Project (WX20M01)
This publication has 192 references indexed in Scilit:
- hnRNPA2B1 drives colorectal cancer progression via the circCDYL/EIF4A3/PHF8 axisThe Kaohsiung Journal of Medical Sciences, 2025
- Colorectal cancer: Review of signaling pathways and associated therapeutic strategiesJournal of Surgical Oncology, 2023
- The catalytic domains of all human KDM5 JmjC demethylases catalyse N‐methyl arginine demethylationFEBS Letters, 2023
- Epigenetic regulation of cancer stem cell formation and maintenanceInternational Journal of Cancer, 2020
- Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3‐mediated down‐regulation of E‐cadherinJournal of Cellular Physiology, 2017
- Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and ProgressJournal of Cellular Biochemistry, 2017
- Role of Wnt/β‐catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancerJournal of Cellular Physiology, 2017
- The Notch pathway in colorectal cancerInternational Journal of Cancer, 2015
- The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cellsJournal of Cellular Biochemistry, 2011
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancersInternational Journal of Cancer, 2010